By clicking “View Open Positions”, you acknowledge and consent to your personal information being transferred cross-border to Pivotal Headquarters in Hong Kong. For more details, please refer to the Recruitment Privacy Policy.
SanReno
THERAPEUTIC AREA
Renal
YEAR INVESTED
2021
STAGE
Private; acquired by Novartis in 2024
WEBSITE
Sanreno is a biotech company dedicated to developing therapies for kidney diseases and related conditions. With a focus on research, development, and commercialization, Sanreno aims to bring innovative treatments to market that enhance the quality of life for patients affected by kidney-related health issues.
SHANGHAI
Suite 2001, YI FUNG PLACE
99 West Ziyun Road
Changning District
Shanghai 200051, China
HONG KONG
17th Floor
AIRSIDE
2 Concorde Road, Kai Tak
Hong Kong SAR
SAN FRANCISCO
501 2nd Street, Suite 200
San Francisco, CA 94107
United States
中文
English
